(Q36698651)

15 August 2017

1 reference

title

Irritable bowel syndrome in the 21st century: perspectives from Asia or South-east Asia (English)

1 reference

15 August 2017

main subject

irritable bowel syndrome

1 reference

Full-Young Chang

1

1 reference

15 August 2017

Ching-Liang Lu

series ordinal

2

1 reference

15 August 2017

publication date

1 January 2007

1 reference

Journal of Gastroenterology and Hepatology

15 August 2017

published in

1 reference

15 August 2017

volume

22

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

4-12

1 reference

Management of the irritable bowel syndrome

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Diagnosis and therapy of irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Economic burden of irritable bowel syndrome. Proposed strategies to control expenditures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

AGA technical review on irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

The impact of irritable bowel syndrome on health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Treatment of irritable bowel syndrome: a review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Irritable bowel syndrome: a little understood organic bowel disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

New pathophysiological mechanisms in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

The management of irritable bowel syndrome: a European, primary and secondary care collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Irritable bowel syndrome: basis of clinical management strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Irritable bowel syndrome neuropharmacology. A review of approved and investigational compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Serotoninergic neuroenteric modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Treating irritable bowel syndrome: overview, perspective and future therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Clinical assessment of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

A population study on irritable bowel syndrome and mental health

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Current patterns of irritable bowel syndrome in Taiwan: the Rome II questionnaire on a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Systematic review: the influence of geography and ethnicity in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

A study of irritable bowel syndrome diagnosed by Manning criteria in an African population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Irritable bowel-type symptoms in HMO examinees. Prevalence, demographics, and clinical correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Irritable bowel syndrome in a rural community in Bangladesh: prevalence, symptoms pattern, and health care seeking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Prevalence of irritable bowel syndrome, influence of lifestyle factors and bowel habits in Korean college students

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Prevalence of irritable bowel syndrome in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Epidemiology of irritable bowel syndrome in Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Prevalence of irritable bowel syndrome in young adult Malaysians: a survey among medical students

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Review article: current management of alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an asian urban community

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

A population-based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Irritable bowel syndrome in developing countries--a disorder of civilization or colonization?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Bowel habit subtypes and temporal patterns in irritable bowel syndrome: systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

The IBS-36: a new quality of life measure for irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

The association between Helicobacter pylori infection and functional dyspepsia in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Irritable bowel syndrome. Diagnosis in the managed care era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Irritable bowel syndrome: the influence of psychological factors on the symptom complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Psychometric scores and persistence of irritable bowel after infectious diarrhoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Gender difference on the symptoms, health-seeking behaviour, social impact and sleep quality in irritable bowel syndrome: a Rome II-based survey in an apparent healthy adult Chinese population in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Colonic tone and motility in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Characteristics of small bowel motility in patients with irritable bowel syndrome and normal humans: an Oriental study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Effect of a calcium channel blocker and antispasmodic in diarrhoea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Ambulatory abdominal inductance plethysmography: towards objective assessment of abdominal distension in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Altered rectal perception is a biological marker of patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Role of serotonin in the pathophysiology of the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Brain-gut axis in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

East meets West: infection, nerves, and mast cells in the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Safety and tolerability of tegaserod in patients with irritable bowel syndrome and diarrhea symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Use of diet and probiotic therapy in the irritable bowel syndrome: analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

Learning needs of Taiwanese nurses caring for patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04672.X

10.1111/J.1440-1746.2006.04672.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference